What Is an ESOP, and How Does Vesting Actually Work?

An ESOP (Employee Stock Option Plan) gives an employee the right to buy a set number of company shares at a fixed price in the future, regardless of what the shares are actually worth by then. It's not a stock grant — you don't own anything the day it's offered — and it's not automatic income either. It's an option, in the literal sense: a right, not an obligation, to buy in later at today's price. Startups use ESOPs heavily because they let a company offer meaningful long-term upside without paying it out in cash today, which matters a lot when cash is the scarcest resource a young company has.

The core terms you need to actually understand

• Grant — the formal offer of a specific number of options, documented in a grant letter that specifies quantity, exercise price, and vesting schedule.
• Exercise price (or strike price) — the fixed price per share you'll pay if you choose to convert your vested options into actual shares. This is usually set at (or close to) the company's fair market value on the date of the grant.
• Vesting — the process of "earning" the right to exercise your options over time, typically tied to continued employment. Unvested options are simply forfeited if you leave before they vest.
• Cliff — an initial waiting period (commonly one year) before any options vest at all. Leave before the cliff, and you walk away with zero — not a partial amount.
• Exercise — the act of actually paying the exercise price to convert vested options into real, owned shares.
• Exercise window — the limited time you have to exercise vested options after leaving the company, often 90 days, though some companies now offer extended windows of a year or more.

A typical vesting schedule, worked through with real numbers

The most common structure in Indian and global startups alike is a four-year vesting period with a one-year cliff. Say you're granted 4,800 options on the day you join. For the entire first year, you vest nothing — this is the cliff. On your first anniversary, 25% (1,200 options) vests all at once. From that point, the remaining 75% typically vests monthly or quarterly in equal instalments over the next three years — for monthly vesting, that's roughly 100 options a month for 36 months. If you leave after 18 months, you'd have the 1,200 that vested at the cliff plus roughly 6 more months of monthly vesting (around 600 more), for a total of about 1,800 vested options — and the remaining 3,000 are simply forfeited back to the company's option pool.

Why the cliff exists

The cliff isn't arbitrary — it exists specifically to protect the company (and, indirectly, the other employees sharing the same option pool) from someone joining, receiving a grant, and leaving within a few months while still walking away with equity. From an employee's side, it does mean the first year genuinely carries zero equity payoff if you leave early, which is worth weighing honestly if there's real uncertainty about whether the role is a good fit before you commit to it for a year.

Exercising your options — what it actually costs

Vesting only earns you the *right* to buy shares — it doesn't hand them to you for free. To actually own the shares, you exercise: paying (number of vested options) × (exercise price) out of your own pocket. If your exercise price is ₹10 per share and you have 1,200 vested options, exercising all of them costs ₹12,000 upfront, regardless of what those shares might be worth on paper. This is the detail that surprises people most — a large ESOP grant can mean a real, sometimes substantial cash outlay to actually convert it into ownership, well before there's any liquidity event to sell those shares and recover that cash.

The exercise window problem when you leave

This is arguably the least understood — and most consequential — part of the whole system. When you leave a company (voluntarily or otherwise), you typically have a strict exercise window, often just 90 days, to decide whether to pay the exercise price for your vested options or forfeit them entirely. For an employee at a company that hasn't gone public or been acquired, this creates a genuinely difficult decision: pay real cash, today, for shares that are illiquid and might ultimately be worth nothing, purely to keep the *option* to benefit later if the company succeeds. Some companies have moved to more employee-friendly extended exercise windows (a year or longer) specifically to reduce this pressure — when evaluating an offer, this term is worth asking about directly, because it materially changes how much risk you're actually taking on.

How ESOPs are taxed in India — two separate tax events

This is where many employees get caught off guard, because tax is triggered twice, at two very different points, and the first one hits before you've received any cash at all.

• At exercise: the difference between the share's fair market value (FMV) on the exercise date and your exercise price is treated as a perquisite — taxable as salary income at your slab rate, in the year you exercise. Critically, this tax is owed even though you haven't sold anything and have no actual cash from the shares yet — you're taxed on paper gains at exercise.
• At sale: when you eventually sell the shares, any further gain over the FMV at exercise (which becomes your new cost basis) is taxed as a capital gain — long-term or short-term depending on the holding period, with different rates for listed versus unlisted shares.
• Eligible startups exception: employees of DPIIT-recognised eligible startups have historically had access to a deferral mechanism on the perquisite tax at exercise (pushing that tax liability to a later trigger like sale, resignation, or a set number of years) — but eligibility criteria and the exact deferral rules are specific and change with policy updates, so this needs to be checked against current rules for your specific company, not assumed.

ESOPs vs RSUs — a distinction worth knowing even if you've only heard "stock options"

Employees moving between an Indian startup and a larger tech company (or a company that's already gone public) often hear "RSU" used almost interchangeably with ESOP, but they work differently in one important way. An ESOP is an option — you pay an exercise price to convert it into a share, and if the share price ever falls below your exercise price, the option can genuinely be worth nothing (it's simply not worth exercising). A Restricted Stock Unit (RSU), by contrast, is a promise of actual shares delivered to you for free once it vests — no exercise price, no purchase decision required. RSUs are more common at larger, typically already-public companies where the share price is known and relatively stable; ESOPs dominate at earlier-stage startups precisely because there's no established share price yet to grant stock at directly, and the option structure lets the company set a low exercise price today against a share value it hopes will be much higher later. If an offer letter says "stock options," confirm which of the two you're actually being offered — the downside risk and the tax treatment both differ.

The core risk that makes ESOPs different from a cash bonus

A cash bonus has a fixed, known value the moment it's paid. An ESOP's value depends entirely on an event that may never happen — the company going public, being acquired, or otherwise providing liquidity for shareholders to actually sell their shares. Until that happens, the shares (or even the vested options) are essentially illiquid — you can't spend them, and in the meantime the company may also raise more funding at terms that dilute your ownership percentage (though ideally at a higher valuation per share, which can offset the dilution in absolute value, but isn't guaranteed to). The honest way to think about an ESOP grant is as a long-dated, illiquid, dilution-exposed bet on the company's future — worth potentially a lot, or potentially nothing, and genuinely unknowable at the time you accept the offer.

How to actually evaluate an ESOP offer, practically

• Ask for the percentage, not just the number of options — 10,000 options sounds impressive until you learn the company has 500 million shares outstanding. What matters is the percentage of the fully diluted company you're being offered.
• Ask what the exercise price is based on — a recent, credible 409A-style or independent valuation is a healthier sign than a number nobody can explain.
• Ask about the exercise window on departure — a 90-day window versus an extended one materially changes your real risk if you ever leave.
• Ask whether the company has had, or expects, a liquidity event — secondary share sales, a recent funding round at a much higher valuation, or IPO/acquisition plans are the only things that actually turn paper equity into real money.
• Never treat ESOP value as a substitute for adequate cash compensation — evaluate the cash salary on its own merits first, and treat the ESOP as genuine, real, but separately-risked upside on top of it, not a reason to accept below-market cash pay.

Liquidity events — the only thing that actually turns paper value into money

There are, in practice, three ways vested and exercised ESOP shares ever become real, spendable money: an IPO, where the company lists publicly and shares can be sold on an open exchange; an acquisition, where the acquiring company buys out shareholders (including employees who've exercised) as part of the deal; and a secondary sale, where a growing but still-private company organises a structured buyback or allows existing shareholders (sometimes including employees) to sell a portion of their shares to new or existing investors at the current valuation, without waiting for a full IPO or acquisition. Secondary sales and structured buyback programs have become meaningfully more common among well-funded Indian startups specifically because the gap between an early ESOP grant and an eventual IPO can stretch to a decade or more — a buyback gives employees at least partial liquidity along the way, rather than asking them to wait indefinitely for one of the other two events. When evaluating an offer, asking whether the company has run (or plans to run) periodic buybacks is a genuinely useful question, since it directly affects how illiquid your equity is likely to stay.

ESOPs from the founder's side

Founders setting up an ESOP pool face their own trade-offs: a larger pool is more attractive to early employees and easier to use for competitive hiring, but it further dilutes founders' and existing investors' ownership. Most startups carve out an ESOP pool of somewhere between 8% and 15% of fully diluted equity at an early stage, refreshed periodically as the pool gets used up through new grants and as the company grows. Investors in a priced funding round frequently negotiate the ESOP pool size (and whether it's created before or after the round, which affects whose ownership actually absorbs the dilution) as part of the term sheet — a detail that's easy to gloss over but has a real, quantifiable effect on founder ownership by the time of a later exit.

The short version: an ESOP is a genuine, potentially significant form of compensation, but it's fundamentally different from cash — it's earned gradually through vesting, costs real money to exercise, is taxed at exercise even before you've sold anything, and only becomes actual liquid value if the company eventually provides a way to sell the shares. None of that makes it worthless — plenty of early employees at successful companies have made ESOPs the most valuable part of their compensation — but it does mean evaluating an offer requires asking the specific questions above rather than taking the headline number at face value.